Piramal Pharma Q2 Results

  • BSE: 543635
  • NSE: PPLPHARMA
  • ISIN: INE0DK501011
  • Sector: -
BSE
227.45-5.20 (-2.24%)
Volume2.55 L
Updated: Fri 13 Sep, 2024 | 15:57:27
NSE
228.11-4.56 (-1.96%)
Volume6.72 M
Updated: Fri 13 Sep, 2024 | 15:43:45
Today: 225.40
234.65
52-Wk: 87.55
244.10

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Piramal Pharma Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 1,911.381,748.859.29%
    Selling/ General/ Admin Expenses Total 516.03495.544.13%
    Depreciation/ Amortization 184.51173.616.28%
    Other Operating Expenses Total -49.19-38.3128.40%
    Total Operating Expense 1,289.081,257.572.51%
    Operating Income 622.30491.2826.67%
    Net Income Before Taxes 39.56-107.110.00%
    Net Income 5.02-98.580.00%
    Diluted Normalized EPS 0.04-0.830.00%

    Piramal Pharma Q2 News

    Piramal Pharma revenue up 11% to ₹1,911 crore in Q2
    1 min read28 Oct 2023
    More From News

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

        HomeMarketsPremiumInstant LoanMint Shorts

        Wait for it…

        Log in to our website to save your bookmarks. It'll just take a moment.

        Yes, Continue